Shuttle Pharmaceuticals Holdings, Inc.
SHPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $6 | $61 |
| Gross Profit | $0 | $0 | -$6 | -$61 |
| % Margin | – | – | – | – |
| R&D Expenses | $3,619 | $3,517 | $1,047 | $1,022 |
| G&A Expenses | $4,077 | $2,375 | $0 | $721 |
| SG&A Expenses | $4,077 | $2,375 | $1,290 | $721 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$61 |
| Operating Expenses | $7,696 | $5,892 | $2,338 | $1,682 |
| Operating Income | -$7,696 | -$5,892 | -$2,344 | -$1,743 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1,449 | -$700 | -$2,652 | $591 |
| Pre-Tax Income | -$9,145 | -$6,593 | -$4,996 | -$1,152 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9,145 | -$6,593 | -$4,996 | -$1,152 |
| % Margin | – | – | – | – |
| EPS | -885.73 | -0.41 | -0.3 | -0.095 |
| % Growth | -215,931.7% | -36.7% | -217.5% | – |
| EPS Diluted | -885.73 | -0.41 | -0.3 | -0.095 |
| Weighted Avg Shares Out | 10,325 | 15,907 | 10,351 | 13,586 |
| Weighted Avg Shares Out Dil | 10,325 | 15,907 | 10,351 | 13,586 |
| Supplemental Information | – | – | – | – |
| Interest Income | $38 | $79 | $0 | $0 |
| Interest Expense | $1,360 | $2,595 | $671 | $51 |
| Depreciation & Amortization | $5 | $7 | $6 | $61 |
| EBITDA | -$7,779 | -$3,991 | -$4,319 | -$1,041 |
| % Margin | – | – | – | – |